Fertility preservation during cancer treatment

   Rated 0 / 5 stars

Save

CPD for this activity

Educational Activities (EA)

0.5 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0.5 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
0.5 mins

Educational Activities (EA)
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0.5 mins

Reviewing Performance (RP)
These are activities that require reflection on feedback about your work.

MO
0 mins

Measuring Outcomes (MO)
These are activities that use your work data to ensure quality results.

Listen to the episode

Description

In this episode:

  • The ways in which cancer therapies may impact on subsequent fertility
  • The importance of addressing fertility issues in those facing chemotherapy/radiotherapy
  • Techniques to preserve fertility in both male and female patients before and after cancer therapy
  • Preserving fertility in prepubescent patients
  • The main limitations of fertility preservation techniques

 

Host: Dr Terri Foran, Sexual Health Physician; Conjoint Senior Lecturer, School of Women’s and Children’s Health, UNSW

Guest: A/Prof Kate Stern, Specialist, Gynaecologist and Reproductive Endocrinologist; Associate Professor of Obstetrics and Gynaecology, University of Melbourne, Royal Women’s Hospital; Clinical Director and Head of Clinical Research, Melbourne IVF

Total time: 21 mins

 

Recommended Resources:

 

Last Updated: 23 Nov, 2021

Rate this podcast
Help your colleagues find podcasts they'll enjoy by rating this podcast out of five stars.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Fiona Chan

Dr Fiona Chan

Multiple Sclerosis vs Antibody Disease – What GPs Need to Know

Prof Andrew Sindone & Dr Ted Wu

Prof Andrew Sindone & Dr Ted Wu

Using SGLT2 to Reduce Cardiovascular Death in T2D – Important Updates for GPs

Prof Rod Baber

Prof Rod Baber

Menopause and MHT: Maximising Benefits & Minimising Risks

Dr Shannon Thomas

Dr Shannon Thomas

Peripheral Arterial Disease

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

A/Prof Kate Stern

expert

A/Prof Kate Stern

Specialist, Gynaecologist and Reproductive Endocrinologist; Associate Professor of Obstetrics and Gynaecology, University of Melbourne, Royal Women’s Hospital; Clinical Director and Head of Clinical Research, Melbourne IVF

Recent articles

Find your area of interest

Share this

You have completed the Educational Activities (EA) component of this activity.

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.

Menopause and MHT

Multiple sclerosis vs antibody disease

Using SGLT2 to reduce cardiovascular death in T2D

Peripheral arterial disease